Xtx Topco LTD Immix Biopharma, Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 52,197 shares of IMMX stock, worth $110,135. This represents 0.02% of its overall portfolio holdings.

Number of Shares

52,197

Holding current value

$110,135

% of portfolio

0.02%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.64 - $6.68 $137,800 - $348,675	52,197 New	52,197 $160,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.97 $16,889 - $38,586	-12,992 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.86 - $6.75 $24,165 - $87,696	12,992 New	12,992 $31,000

Others Institutions Holding IMMX

# of Institutions

Shares Held

5.09M

Call Options Held

Put Options Held

Aigh Capital Management LLC Baltimore, MD

1.56M
Shares

$3.28 Million
1.92% of portfolio
Bleichroeder LP New York, NY

850K
Shares

$1.79 Million
0.81% of portfolio
Cable Car Capital LLC San Francisco, CA

670K
Shares

$1.41 Million
2.84% of portfolio
Vanguard Group Inc Valley Forge, PA

456K
Shares

$962,552
0.0% of portfolio
Lynwood Capital Management Inc.

405K
Shares

$854,550
11.13% of portfolio

View Full List

About Immix Biopharma, Inc.

Ticker IMMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,910,100
Market Cap $29.4M
Description
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...

More about IMMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account